Market Research Report
Stem Cell Research Products - Opportunities, Tools & Technologies
|Published by||BIOINFORMANT WORLDWIDE, LLC||Product code||238169|
|Published||Content info||175 Pages
|Stem Cell Research Products - Opportunities, Tools & Technologies|
|Published: April 30, 2016||Content info: 175 Pages||
This global strategic report evaluates strategies across the entire stem cell product spectrum, with emphasis on opportunities for stem cell research product development. It explores unique market opportunities by stem cell type, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and more.
The possibilities arising from stem cells have resulted in great commercial interest, with potential applications ranging from their use in the reversal of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, toxicology assessment, and more.
Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding their use. Although some adult stem cells do have differentiation capacity, it is often limited, which results in fewer options for use.
Thus, when induced pluripotent stem cells (iPSCs) were produced from mouse cells in 2006 by Shinya Yamanaka of Kyoto University in Japan, they represented a promising combination of adult and embryonic stem cell characteristics. By 2007, a series of follow-up experiments were done at Kyoto University in which human adult cells were transformed into iPSC cells. Nearly simultaneously, a research group led by James Thomson at the University of Wisconsin-Madison accomplished the same feat of deriving iPSC lines from human somatic cells.
To facilitate research resulting from interest in these potential far-ranging applications, a large and growing stem cells research products market has emerged.
While several of these dominant market players have utilized acquisition strategies to grow and capture market share, Merck KGaA has had a particularly strong commitment to this approach, acquiring several other massive major players within the stem cell research products marketplace, including Milllipore on February 26, 2010, for $7.2 billion, and Sigma-Aldrich on September 22, 2014, for $17 billion. Dozens of mid-sized suppliers of stem cell research products also exist, as well as over 100 small specialty providers.
A distinctive feature of this report is an end-user survey of 289 researchers worldwide that identify as having stem cells as their research focus. These survey findings reveal researcher needs, technical preferences, key factors influencing buying decisions, and more.
The findings can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.
Claim this report to acquire an understanding of stem cell market trends, efficiently target emerging opportunities, and accurately identify the current and future needs of your client base.
The content and statistics contained in this report were compiled using a broad range of sources. These input sources include: